Saquinavir Cardiac Warning Label
Links shared publicly online about this topic
Cardiac Warning Added to HIV Drug's Label
hcplive.com — “The FDA has released a statement notifying physicians and patients that the combination of saquinavir and ritonavir can lead to abnormal heart rhythm.” View full resource at hcplive.com
Most Recently Shared on November 2, 2010 at 2:54 pm By:
Cardiac Warning Added to HIV Drug's Label http://hcp.lv/anarm8
FDA Alert: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm
drugs.com — “FDA Alert: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm” View full resource at drugs.com
Most Recently Shared on October 21, 2010 at 8:52 pm By:
FDA Alert - Labeling Change for Invirase (saquinavir) - Risk of Abnormal Heart Rhythm - http://bit.ly/9nxaPY
FDA Alert: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm
drugs.com — “FDA Alert: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm” View full resource at drugs.com
Most Recently Shared on October 21, 2010 at 9:06 pm By:
Drugs and Devices OW OW Health
Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm: Audience: Cardiology, Infectious Disease ... http://bit.ly/at3Bk4 #FDA
Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm
fda.gov — “Prolonged QT or PR intervals reported when Invirase is used with the antiviral medication, Norvir (ritonavir).” View full resource at fda.gov
Most Recently Shared on October 21, 2010 at 7:58 pm By:
Trish D'Antonio Health Professional
Getting the word out: FDA: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm (http://bit.ly/9sMymg)
Invirase labeling updated to include cardiac risk with Norvir - ONA
oncologynurseadvisor.com — “The FDA announced that new safety information has been added to the label for Invirase (saquinavir, from Genentech), describing potentially life-threatening cardiac effects when used with Norvir (ritonavir, from Abbott).” View full resource at oncologynurseadvisor.com
Most Recently Shared on October 21, 2010 at 7:21 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Invirase labeling updated to include cardiac risk with Norvir http://goo.gl/fb/3HTNM
Invirase labeling updated to include cardiac risk with Norvir - MPR
empr.com — “The FDA announced that new safety information has been added to the label for Invirase (saquinavir, from Genentech), describing potentially life-threatening cardiac effects when used with Norvir (ritonavir, from Abbott).” View full resource at empr.com
Most Recently Shared on October 21, 2010 at 9:06 pm By:
MPR News: Invirase labeling updated to include cardiac risk with Norvir: The FDA announced that new safety informa... http://bit.ly/9u5okh
US health agency warns of heart problems from HIV drugs
health.yahoo.net — “US health officials warned Thursday of the threat of cardiac arrest by combining two antiviral drugs used to medicate HIV.” View full resource at health.yahoo.net
Most Recently Shared on October 21, 2010 at 9:36 pm By:
Jennifer Ann Grisso Nurse and Active Health Library
US health agency warns of heart problems from HIV drugs: US health officials warned Thursday of the threat of card... http://bit.ly/cdd1wm
US health agency warns of heart problems from HIV drugs
health.yahoo.net — “US health officials warned Thursday of the threat of cardiac arrest by combining two antiviral drugs used to medicate HIV.” View full resource at health.yahoo.net
Most Recently Shared on October 21, 2010 at 10:41 pm By:
US health agency warns of heart problems from HIV drugs http://bit.ly/bIsLaF
New Label Changes for Commonly Prescribed HIV Drug Invirase
fda.gov — “HIV, Invirase, heart” View full resource at fda.gov
Most Recently Shared on October 21, 2010 at 4:04 pm By:
eyeonfda Pharma and Health Lawyer
FDA on New Label Changes for Commonly Prescribed HIV Drug Invirase - http://ow.ly/2XcJg
New Label Changes For Commonly Prescribed HIV Drug Invirase
medicalnewstoday.com — “The U.S. Food and Drug Administration announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir), describing potentially life-threatening si” View full resource at medicalnewstoday.com
Most Recently Shared on October 22, 2010 at 7:05 pm By:
New Label Changes For Commonly Prescribed HIV Drug Invirase http://mnt.to/3LCR #hivaids
New Label Changes for Commonly Prescribed HIV Drug Invirase - Drugs.com MedNews
drugs.com — “Drug associated with a life-threatening heart abnormality when used with another antiviral medicine The U.S. Food and Drug Administration today announced that n” View full resource at drugs.com
Most Recently Shared on October 21, 2010 at 10:10 pm By:
Drugs and Devices OW OW Health
New Label Changes for Commonly Prescribed HIV Drug Invirase: Drug associated with a life-threatening heart ab... http://bit.ly/9v0lDD #drug
Taken together, HIV antiviral drugs Invirase and Norvir could cause lethal heart problems, FDA warns - latimes.com
latimes.com — “The Food and Drug Administration has amped up warnings on the label of the commonly prescribed HIV antiviral, adding information about potentially life-threatening cardiac side effects when used in tandem with Norvir, another widely used antiviral.” View full resource at latimes.com
Most Recently Shared on October 21, 2010 at 10:13 pm By:
LA Times Health News Health News
Taken together, HIV antiviral drugs Invirase and Norvir could cause lethal heart problems, FDA warns http://lat.ms/dsUKni
Heart Warning Added to Label on Popular Antipsychotic Drug - NYTimes.com
nytimes.com — “AstraZeneca will add warnings to labels for Seroquel saying that the drug should be avoided in combination with 12 medicines linked to arrhythmia.” View full resource at nytimes.com
Most Recently Shared on July 21, 2011 at 2:03 am By:
Dr Kelly Sennholz Physician, Doctor, Internist, and Emergency Physician
RT @doctorwes: Seroquel gets black box warning regarding excess cardiac arrhythmias and prolonged QT http://t.co/EUcudBO
Medical News: Fenofibric Acid May Not Cut Cardiac Risk, FDA Warns - in Cardiovascular, Dyslipidemia from MedPage Today
medpagetoday.com — “The FDA has ordered that the label for fenofibric acid (Trilipix) be changed to indicate that the lipid-lowering drug has not been shown to reduce the risk of heart attack or stroke.” View full resource at medpagetoday.com
Most Recently Shared on November 9, 2011 at 6:04 pm By:
FDA ordered the label for fenofibric acid to indicate that it hasn't shown to reduce risk of heart attack & stroke http://t.co/ug89saXQ
FDA: Warnings for HIV, prostate drugs | theheart.org
theheart.org — “The latest developments in cardiology and cardiovascular research, including breaking heartwire news and commentary by some of the world's most prominent cardiologists.” View full resource at theheart.org
Most Recently Shared on October 22, 2010 at 11:49 pm By:
Tammi Jacobs Health Professional
FDA: Warnings for HIV, prostate drugs | theheart.org http://bit.ly/9xwGwo
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
HCPLive_Cardio
Your online destination for Cardiology news,events,and resources
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
